NASDAQ:STAB Statera Biopharma (STAB) Stock Price, News & Analysis → They say it’s ‘unstoppable’ – How I made 43,509% (From Investing Daily) (Ad) Free STAB Stock Alerts $0.0007 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.0007▼$0.000750-Day Range N/A52-Week Range$0.00▼$0.04Volume401 shsAverage Volume5,543 shsMarket Capitalization$38,262.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media Get Statera Biopharma alerts: Email Address Ad Investing DailyThey say it’s ‘unstoppable’ – How I made 43,509% Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About Statera Biopharma Stock (NASDAQ:STAB)Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. Statera Biopharma, Inc. is based in Fort Collins, Colorado.Read More STAB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart STAB Stock News HeadlinesApril 18, 2024 | morningstar.comStatera BioPharma Inc Ordinary SharesApril 12, 2024 | finance.yahoo.comCRAIG D. LINDER SELECTED TO 2024 TOP 50 LAWYERS IN AMERICAApril 27, 2024 | Prosper Trading Academy (Ad)This AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?April 7, 2024 | bbc.comArrests after man found with serious stab injuriesApril 4, 2024 | bbc.comPolice appeal after man found with stab injuriesFebruary 25, 2024 | wsj.comAEON Biopharma Inc.January 30, 2024 | investing.comMereo BioPharma Group PLC ADR (MREO)December 14, 2023 | bbc.comCrookes curry house knife used to stab teenager to deathApril 27, 2024 | Prosper Trading Academy (Ad)This AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?December 9, 2023 | bbc.comLeeds stab death: Police name victim of Chapeltown attackNovember 25, 2023 | bbc.co.ukTwo boys, 12, in court charged with Wolverhampton stab murderNovember 25, 2023 | bbc.co.ukWolverhampton: Two boys, 12, arrested over stab murder of manNovember 11, 2023 | morningstar.comARCA biopharma Inc ABIONovember 10, 2023 | nbcnews.comCornell University student threatened to stab and rape Jewish students and ‘shoot up’ school, prosecutors sayOctober 31, 2023 | morningstar.comPOINT Biopharma Global Inc Ordinary Shares PNTOctober 29, 2023 | nypost.comElianne Andam died from ‘multiple stab wounds’ in ‘brutal’ attackOctober 23, 2023 | benzinga.comSutro Biopharma Stock (NASDAQ:STRO), Analyst Ratings, Price Targets, PredictionsOctober 12, 2023 | bbc.comMurder arrest over man's stab death in HaringeyOctober 11, 2023 | mirror.co.ukBristol stab death victim's family 'heartbroken' as woman in 'hate crime' arrestOctober 6, 2023 | bbc.co.ukHigh Wycombe: Two men held over teen's stab deathJuly 31, 2023 | mirror.co.ukChilling moment teen killers stab wrong boy with ninja sword in mistaken identity murderMay 7, 2023 | abcnews.go.comAutopsy: Stab wounds to heart, lungs killed Cash App founderMay 2, 2023 | news.yahoo.com‘Don’t let him stab him:’ Police release video of suspect shot, killed attempting to stab police K-9March 15, 2023 | finance.yahoo.comStatera Biopharma Signs Letter of Intent for Merger with Worksite LabsJanuary 27, 2023 | seekingalpha.comSTAB Statera Biopharma, Inc.January 24, 2023 | finanznachrichten.deStatera Biopharma Announces Completion of Application Process to Uplist to the OTCQB Venture MarketplaceJanuary 24, 2023 | finance.yahoo.comStatera Biopharma Announces Completion of Application Process to Uplist to the OTCQB(R) Venture MarketplaceSee More Headlines Receive STAB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Statera Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Next Earnings (Estimated)5/17/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:STAB CUSIPN/A CIK1318641 Webwww.staterabiopharma.com Phone(888) 613-8802Fax716-849-6820Employees46Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.49 million Price / Sales0.03 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares54,660,000Free Float51,656,000Market Cap$38,262.00 OptionableNot Optionable Beta0.47 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Michael Kevin Handley (Age 52)CEO, President & Chairman of the Board Comp: $2.87MMr. Christopher Zosh (Age 48)Executive VP of Finance, Interim Principal Financial Officer & Interim Principal Accounting Officer Dr. Robert W. Buckheit Jr. (Age 64)Ph.D., Chief Technology Officer Key CompetitorsNovanNASDAQ:NOVNNVN LiquidationNASDAQ:NOVNQScopus BioPharmaNASDAQ:SCPSCalithera BiosciencesNASDAQ:CALAIgnyte AcquisitionNASDAQ:IGNYView All Competitors STAB Stock Analysis - Frequently Asked Questions How have STAB shares performed in 2024? Statera Biopharma's stock was trading at $0.0006 on January 1st, 2024. Since then, STAB stock has increased by 16.7% and is now trading at $0.0007. View the best growth stocks for 2024 here. When is Statera Biopharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, May 17th 2024. View our STAB earnings forecast. How do I buy shares of Statera Biopharma? Shares of STAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:STAB) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Statera Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
